These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 6237843

  • 1. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN, Potortì F, Urbano O, Perroni GB.
    Minerva Cardioangiol; 1988 May 15; 36(5):249-52. PubMed ID: 3059229
    [No Abstract] [Full Text] [Related]

  • 3. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 4. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G, Trübestein R, Ludwig M.
    Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437
    [Abstract] [Full Text] [Related]

  • 5. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs].
    Warembourg G, Carre A, Ginestet A, Lambert M.
    Lille Med; 1976 Dec 20; 21 Suppl 4():898-901. PubMed ID: 1018614
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Dec 20; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 7. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V, Margheriti R, Matone P, Morrieri C, Rugolo A, Corsi V.
    Clin Ter; 1986 Jun 30; 117(6):499-509. PubMed ID: 3527536
    [No Abstract] [Full Text] [Related]

  • 8. [Diagnostic value of intra-arterial buflomedil, during arteriography of the limbs].
    Flageat J, Vicens JL.
    Ann Radiol (Paris); 1988 Jun 30; 31(6):379-84. PubMed ID: 3239945
    [No Abstract] [Full Text] [Related]

  • 9. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F, Perbellini A, Adami CA, Dal Cortivo G, Bucci S.
    Clin Ter; 1986 Dec 15; 119(5):379-85. PubMed ID: 2951055
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T, Kallel N, Guediche M.
    Tunis Med; 1986 May 15; 64(5):475-80. PubMed ID: 3824555
    [No Abstract] [Full Text] [Related]

  • 11. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J, Kieny R, Le Bas P, Benhamou M, Molkhou JM.
    Ann Cardiol Angeiol (Paris); 1989 Jun 15; 38(6):339-42. PubMed ID: 2667444
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK.
    Med Welt; 1973 Sep 28; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract] [Full Text] [Related]

  • 13. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
    Kurbangaleev SM, Savel'ev IuS.
    Vestn Khir Im I I Grek; 1974 Oct 28; 113(10):68-71. PubMed ID: 4432347
    [No Abstract] [Full Text] [Related]

  • 14. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 28; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 15. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S, Manganaro A, Barbera MC, Cento D, Buda D, Arrigo F, Consolo F.
    Minerva Cardioangiol; 1986 Nov 28; 34(11):745-9. PubMed ID: 2949163
    [No Abstract] [Full Text] [Related]

  • 16. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 17. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov 24; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug 24; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 19. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P, Pagratis N.
    Angiology; 1981 Oct 24; 32(10):679-85. PubMed ID: 7325404
    [No Abstract] [Full Text] [Related]

  • 20. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.